Physician profile
Brian Sumrall
NPI 1225126154
$5,181.43
in general payments reported to CMS, 2019-2025
35 companies · $337 in 2025
The $337 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $670 · 2021: $1,177 · 2022: $1,345 · 2023: $697 · 2024: $60.76 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075 · Consulting Fee: $19.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.90 |
| Consulting Fee | $19.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,859.54 | 2019-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $893.61 | 2019-2023 | Breztri, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $650.72 | 2019-2023 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $373.02 | 2020-2023 | Cuvitru |
| Grifols USA, LLC | $139.13 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Insmed, INC. | $122.68 | 2023-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $117.67 | 2020-2022 | |
| Philips North America LLC | $92.01 | 2019-2023 | |
| Optinose US, INC. | $70.41 | 2020-2022 | |
| Csl Behring | $63.36 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $63.36 | 2019-2022 | |
| Genzyme Corporation | $61.62 | 2019-2022 | |
| Mylan Specialty L.P. | $57.33 | 2019-2023 | Yupelri |
| Shire North American Group INC | $56.71 | 2019 | |
| Electromed, INC. | $52.07 | 2019-2025 | Smartvest |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $51.06 | 2019-2020 | |
| Pharming Healthcare, INC. | $46.94 | 2020 | |
| Janssen Pharmaceuticals, INC | $41.72 | 2021 | |
| Pulmonx Corporation | $38.34 | 2022-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Abbvie INC. | $33.12 | 2022 | |
| Chiesi USA, INC. | $26.91 | 2019 | |
| Amgen INC. | $26.14 | 2022 | |
| Octapharma USA, INC. | $23.50 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.87 | 2022 | |
| United Therapeutics Corporation | $22.01 | 2021 | |
| Pfizer INC. | $21.00 | 2023 | |
| Biocryst US Sales Co., LLC | $19.90 | 2021 | |
| Adma Biomanufacturing LLC | $19.88 | 2023 | |
| Dexcom, INC. | $19.38 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $18.70 | 2019 | |
| Gilead Sciences, INC. | $17.24 | 2020 | |
| Phadia US INC. | $16.64 | 2022 | |
| Alk-Abello, INC | $14.79 | 2020 | |
| Kaleo, INC. | $14.42 | 2023 | Auvi-Q |
| Hikma Pharmaceuticals USA | $13.63 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sumrall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.